Advertisement
Singapore markets closed

  • Straits Times Index

    3,307.90
    -6.15 (-0.19%)
     

  • Nikkei

    38,946.93
    -122.75 (-0.31%)
     

  • Hang Seng

    19,220.62
    -415.60 (-2.12%)
     

  • FTSE 100

    8,416.45
    -7.75 (-0.09%)
     

  • Bitcoin USD

    69,932.84
    +141.98 (+0.20%)
     

  • CMC Crypto 200

    1,516.39
    +27.85 (+1.87%)
     

  • S&P 500

    5,321.41
    +13.28 (+0.25%)
     

  • Dow

    39,872.99
    +66.22 (+0.17%)
     

  • Nasdaq

    16,832.62
    +37.75 (+0.22%)
     

  • Gold

    2,425.40
    -0.50 (-0.02%)
     

  • Crude Oil

    79.06
    -0.20 (-0.25%)
     

  • 10-Yr Bond

    4.4140
    -0.0230 (-0.52%)
     

  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     

  • Jakarta Composite Index

    7,186.04
    -7,266.69 (-50.28%)
     

  • PSE Index

    6,633.66
    -49.12 (-0.74%)
     

Regulus: 1Q Earnings Snapshot

Regulus: 1Q Earnings Snapshot

Associated Press

SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $3.3 million in its first quarter.

The San Diego-based company said it had a loss of 31 cents per share.

The biopharmaceutical company posted revenue of $6.8 million in the period.

The company's shares closed at $1.25. A year ago, they were trading at $8.71.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS